>
Switch to:

Instil Bio Cash-to-Debt

: No Debt (As of Jun. 2021)
View and export this data going back to 2021. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Instil Bio's cash to debt ratio for the quarter that ended in Jun. 2021 was No Debt.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Instil Bio could pay off its debt using the cash in hand for the quarter that ended in Jun. 2021.

The historical rank and industry rank for Instil Bio's Cash-to-Debt or its related term are showing as below:

NAS:TIL' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: No Debt

During the past 2 years, Instil Bio's highest Cash to Debt Ratio was No Debt. The lowest was No Debt. And the median was No Debt.

NAS:TIL's Cash-to-Debt is ranked higher than
99% of the 319 Companies
in the Biotechnology industry.

( Industry Median: 10.28 vs. NAS:TIL: No Debt )

Instil Bio Cash-to-Debt Historical Data

The historical data trend for Instil Bio's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instil Bio Annual Data
Trend Dec19 Dec20
Cash-to-Debt
No Debt No Debt

Instil Bio Quarterly Data
Dec19 Mar20 Jun20 Dec20 Mar21 Jun21
Cash-to-Debt Premium Member Only N/A N/A No Debt No Debt No Debt

Competitive Comparison

For the Biotechnology subindustry, Instil Bio's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Instil Bio Cash-to-Debt Distribution

For the Biotechnology industry and Healthcare sector, Instil Bio's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Instil Bio's Cash-to-Debt falls into.



Instil Bio Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Instil Bio's Cash to Debt Ratio for the fiscal year that ended in Dec. 2020 is calculated as:

Instil Bio had no debt.

Instil Bio's Cash to Debt Ratio for the quarter that ended in Jun. 2021 is calculated as:

Instil Bio had no debt.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instil Bio  (NAS:TIL) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Instil Bio Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Instil Bio's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Instil Bio Business Description

Instil Bio logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
3963 Maple Avenue, Suite 350, Dallas, TX, USA, 75219
Instil Bio Inc is a clinical-stage cell therapy company. It is developing tumor infiltrating lymphocytes for the treatment of cancer.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)